Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (Ministero dell’Istruzione, dell’Università e della Ricerca)
- License Information
-
More Information
Article History
Received: 12 December 2024
Accepted: 10 April 2025
First Online: 7 May 2025
Declarations
:
: All authors agreed with this final version.
: Alessandra Lugaresi (A.L.) has served as an Amgen/Horizon, Biogen, Bristol Myers Squibb/Celgene, Merck Serono, Novartis, Roche, Sanofi/Genzyme Advisory Board Member. She received congress and travel/accommodation expense compensations or speaker honoraria from Alexion, Biogen, Merck Serono, Novartis, Roche, Sanofi/Genzyme, and Fondazione Italiana Sclerosi Multipla (FISM). Her institutions received research grants from Novartis and Sanofi/Genzyme. Giannicola Carrozzo (G.C.) reports no competing interests. Federica Pinardi (F.P.) reports no competing interests.
